
2025-06-11 11:36:17
Atovaquone-d4,阿托伐醌D4「同位素标记抑制剂」
生物活性:Atovaquone-d4 is the deuterium labeled Atovaquone. Atovaquone is a medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia[1].
IC50 & Target:Plasmodium
分子量:370.86
Formula:C22H15D4ClO3
CAS 号:2070015-14-2
非标记 CAS:95233-18-4
性状:固体
颜色:Light yellow to yellow
中文名称:阿托伐醌 d4
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Powder:-20°C:3 years,4°C:2 years
In solvent:-80°C:6 months,-20°C:1 month
纯度 & 产品资料
纯度: 99.8%
参考文献
[1]. Looareesuwan, S., et al., Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand. Am J Trop Med Hyg, 1996. 54(1): p. 62-6.
[Content Brief]
推荐新闻
-
发布时间 | 2025-06-24 12:21:29
「同位素标记抑制剂」1-Hydroxyoctadecane-d2
-
发布时间 | 2025-06-24 12:18:02
「同位素标记抑制剂」4-Methoxybenzaldehyde-d3
-
发布时间 | 2025-06-24 12:17:28
「同位素标记抑制剂」N,N-Dimethylacetamide-d6
-
发布时间 | 2025-06-24 12:16:48
「同位素标记抑制剂」Phthalic Acid Anhydride-d4
-
发布时间 | 2025-06-24 12:16:48
「同位素标记抑制剂」Umifenovir-d6 hydrochloride